Susceptibility of Treponema pallidum to host-derived antimicrobial peptides

David L Cox1, Yongcheng Sun, Hsi Liu

  • 1Sexually Transmitted Infections Branch, Division of AIDS, STD and TB Laboratory Research, Center for HIV and STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. dlc6@cdc.gov

Peptides
|March 17, 2004
PubMed

Insights

Human cathelicidin LL-37 and a related rabbit peptide show antimicrobial activity against Treponema pallidum, the syphilis agent. A truncated LL-37 peptide blocked T. pallidum infectivity in rabbits.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • LL-37 is a human cathelicidin with broad-spectrum antimicrobial properties.
  • Antimicrobial peptides are crucial in innate immunity against pathogens.
  • The causative agent of syphilis, Treponema pallidum, remains a significant health concern.

Purpose of the Study:

  • To investigate the antimicrobial activity of human LL-37 and a rabbit CAP-18-derived peptide against Treponema pallidum.
  • To evaluate the efficacy of a truncated LL-37 peptide in blocking T. pallidum infectivity.

Main Methods:

  • Testing the antimicrobial activity of LL-37 and CAP-18 peptides against T. pallidum in vitro.
  • Assessing the salt sensitivity of the antimicrobial effect.
  • Utilizing a rabbit model to evaluate the in vivo infectivity blocking capacity of a truncated LL-37 peptide (WS22-N-amide).

Main Results:

  • Both human LL-37 and the rabbit CAP-18 peptide demonstrated rapid antimicrobial activity against T. pallidum.
  • The antimicrobial activity was found to be salt-sensitive.
  • The synthetic truncated LL-37 peptide WS22-N-amide effectively blocked T. pallidum infectivity in a rabbit model.

Conclusions:

  • Human and rabbit cathelicidin-derived peptides exhibit potent antimicrobial effects against Treponema pallidum.
  • A truncated LL-37 peptide shows therapeutic potential for blocking syphilis infection.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...